S'abonner

Functional status outcomes among white and African-American cardiac patients in an equal access system - 09/08/11

Doi : 10.1016/j.ahj.2006.11.019 
Nancy R. Kressin, PhD a, b, , Mark E. Glickman, PhD a, b, Eric D. Peterson, MD, MPH c, Jeff Whittle, MD, MPH d, e, Michelle B. Orner, MPH a, Laura A. Petersen, MD, MPH f, g
a Center for Health Quality, Outcomes and Economic Research (a VA Health Services Research and Development National Center of Excellence), Bedford VA Medical Center, Bedford, MA 
b Section of General Internal Medicine, Boston University School of Medicine, Boston, MA 
c Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 
d Primary Care Division, Clement J Zablocki VA Medical Center, Milwaukee, WI 
e Department of Medicine, Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI 
f Division of Health Policy and Quality, Houston Center for Quality of Care and Utilization Studies (a VA Health Services Research and Development National Center of Excellence), Houston VA Medical Center, Houston, TX 
g Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, TX 

Reprint requests: Nancy R. Kressin, PhD, Center for Health Quality, Outcomes and Economic Research, VA Medical Center, 200 Springs Road, Building 70 (152), Bedford, MA 01730.

Résumé

Background

Racial disparities exist in invasive cardiac procedure use and, sometimes, in subsequent functional status outcomes. We explored whether racial differences in functional outcomes occur in settings where differences in access and treatment are minimized.

Methods

We conducted a prospective observational cohort study of 1022 white and African-American cardiac patients with positive nuclear imaging studies in 5 VA hospitals. Patients' functional status was assessed at baseline, 6, and 12 months later using the Seattle Angina Questionnaire and the SF-12, controlling for treatment received, clinical, sociodemographic, and psychological characteristics.

Results

There were no significant baseline effects of race on functional status, after adjusting for sociodemographics, comorbid conditions, maximal medical therapy, severity of ischemia on nuclear imaging study, personal attitudes, and beliefs. Although there were no race differences in percutaneous transluminal coronary angioplasty use, there was a trend of African Americans being less likely to undergo coronary artery bypass graft, after 6 months (1.4% vs 6.5%) and 1 year (1.9 vs 6.9%). After adjustment, the decline in the SF12 Physical Component Summary from baseline to 6 months was, on average, 2.4 points less for African Americans than for whites, and at 12 months, Anginal Stability improved 8.4 points more for African Americans. The relative strength and direction of both findings persisted after removing covariates that might be confounded with race, and African Americans decreased less than whites on Physical Limitations, and improved more on Treatment Satisfaction, Anginal Frequency, and Disease Perceptions.

Conclusions

In a setting where differences in access are minimized, so are racial differences in functional status outcomes.

Le texte complet de cet article est disponible en PDF.

Plan


 The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.
 The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (ECV 97-022.2, N Kressin, PI), and the American Heart Association and the Pharmaceutical Roundtable (9970113N, N Kressin, PI).


© 2007  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 153 - N° 3

P. 418-425 - mars 2007 Retour au numéro
Article précédent Article précédent
  • Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction
  • Arik Wolak, Sergei Yaroslavtsev, Guy Amit, Yochai Birnbaum, Carlos Cafri, Shaul Atar, Harel Gilutz, Reuben Ilia, Doron Zahger
| Article suivant Article suivant
  • Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure
  • Thomas P. Olson, Eric M. Snyder, Robert P. Frantz, Stephen T. Turner, Bruce D. Johnson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.